MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
14.92
-0.21 (-1.39%)
Sep 2, 2026, 11:19 AM EDT - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $1.27 billion as of September 2, 2026. Its market cap has decreased by -64.13% in one year.
Market Cap
1.27B
Enterprise Value
834.29M
1-Year Change
-64.13%
Ranking
Category
Stock Price
$14.92
ChartMarket Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.27B, an increase of 35,190.82%. That is a compound annual growth rate of 262.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.27B | 34.98% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.36B |
| Omeros | 1.36B |
| Vor Biopharma | 1.34B |
| Jade Biosciences | 1.34B |
| ORIC Pharmaceuticals | 1.34B |
| Immatics | 1.29B |
| Alpha Tau Medical | 1.29B |
| MannKind | 1.28B |